Elsa V Arocho-Quinones1, Chiang-Ching Huang2, Barney D Ward3, Peter A Pahapill4. 1. Department of Neurosurgery, U.S. Department of Veterans Affairs Medical Center, Milwaukee, Wisconsin, USA; Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. Electronic address: earocho@mcw.edu. 2. Joseph J. Zilber School of Public Health, University of Wisconsin, Milwaukee, Wisconsin, USA. 3. Department of Biophysics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. 4. Department of Neurosurgery, U.S. Department of Veterans Affairs Medical Center, Milwaukee, Wisconsin, USA; Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Abstract
INTRODUCTION: Implant-related infections carry a high morbidity. Infectious rates for neuromodulation implants range from 1% to 9% for deep brain stimulation (DBS), 0% to 10% for spinal cord stimulation (SCS) systems, and 3% to 15% for intrathecal (IT) pump systems. Meanwhile, studies of care bundles report infection rate reduction to 1.0% for SCS and 0.3% for cardiac implants. Herein, we evaluate the effectiveness of an infection prevention bundle (IPB) in minimizing infections after surgeries for neuromodulation implants. METHODS: An IPB focused on preoperative checklists, screening questionnaires, methicillin-resistant and methicillin-sensitive Staphylococcus aureus decolonization, weight-based antibiotic prophylaxis, strict draping and surgical techniques, and wound care education was implemented in our functional neurosurgery division in April 2015. We retrospectively reviewed all surgeries for implantation or replacement of SCS, DBS, and IT pump system components from March 2013 to October 2017. The patients were divided into pre-IPB and post-IPB groups. All procedures were performed by a single surgeon. Each surgical site was considered a unique surgical case. Infection rates were calculated for pre-IPB and post-IPB groups. RESULTS: A total of 688 patients underwent 1161 unique surgical procedures (222 DBS electrodes, 419 IPG, 203 SCS, 317 IT pumps) during the study period. There were 546 pre-IPB and 615 post-IPB surgical procedures. The pre-IPB infection rates were 0%, 1.3%, and 8.7% for SCS, DBS, and IT pumps, respectively. The post-IPB infection rates were 0%, 0.3%, and 1.8% for SCS, DBS, and IT pumps, respectively. CONCLUSIONS: Implementation of a standardized IPB approach reduced the number of infections for all neuromodulation implants studied. This approach can be adopted within any specialty to potentially decrease the incidence of implant-related infections.
INTRODUCTION: Implant-related infections carry a high morbidity. Infectious rates for neuromodulation implants range from 1% to 9% for deep brain stimulation (DBS), 0% to 10% for spinal cord stimulation (SCS) systems, and 3% to 15% for intrathecal (IT) pump systems. Meanwhile, studies of care bundles report infection rate reduction to 1.0% for SCS and 0.3% for cardiac implants. Herein, we evaluate the effectiveness of an infection prevention bundle (IPB) in minimizing infections after surgeries for neuromodulation implants. METHODS: An IPB focused on preoperative checklists, screening questionnaires, methicillin-resistant and methicillin-sensitive Staphylococcus aureus decolonization, weight-based antibiotic prophylaxis, strict draping and surgical techniques, and wound care education was implemented in our functional neurosurgery division in April 2015. We retrospectively reviewed all surgeries for implantation or replacement of SCS, DBS, and IT pump system components from March 2013 to October 2017. The patients were divided into pre-IPB and post-IPB groups. All procedures were performed by a single surgeon. Each surgical site was considered a unique surgical case. Infection rates were calculated for pre-IPB and post-IPB groups. RESULTS: A total of 688 patients underwent 1161 unique surgical procedures (222 DBS electrodes, 419 IPG, 203 SCS, 317 IT pumps) during the study period. There were 546 pre-IPB and 615 post-IPB surgical procedures. The pre-IPBinfection rates were 0%, 1.3%, and 8.7% for SCS, DBS, and IT pumps, respectively. The post-IPBinfection rates were 0%, 0.3%, and 1.8% for SCS, DBS, and IT pumps, respectively. CONCLUSIONS: Implementation of a standardized IPB approach reduced the number of infections for all neuromodulation implants studied. This approach can be adopted within any specialty to potentially decrease the incidence of implant-related infections.
Authors: George M Ghobrial; Vismay Thakkar; Saurabh Singhal; Mark E Oppenlander; Christopher M Maulucci; James S Harrop; Jack Jallo; Srinivas Prasad; Michael Saulino; Ashwini D Sharan Journal: J Clin Neurosci Date: 2014-06-14 Impact factor: 1.961
Authors: Timothy R Deer; David A Provenzano; Michael Hanes; Jason E Pope; Simon J Thomson; Marc A Russo; Tory McJunkin; Michael Saulino; Louis J Raso; Shivanand P Lad; Samer Narouze; Steven M Falowski; Robert M Levy; Ganesan Baranidharan; Stanley Golovac; Didier Demesmin; William O Witt; Brian Simpson; Elliot Krames; Nagy Mekhail Journal: Neuromodulation Date: 2017-01-02
Authors: Leonardo A Frizon; Olivia Hogue; Connor Wathen; Erin Yamamoto; Navin C Sabharwal; Jaes Jones; Josephine Volovetz; Andres L Maldonado-Naranjo; Darlene A Lobel; Andre G Machado; Sean J Nagel Journal: Neuromodulation Date: 2017-05-03
Authors: Richard North; Mehul J Desai; Johan Vangeneugden; Christian Raftopoulos; Tony Van Havenbergh; Marc Deruytter; Jean-Michel Remacle; Jane Shipley; Ye Tan; Mary Jo Johnson; Carine Van den Abeele; Philippe Rigoard Journal: Neuromodulation Date: 2020-04-08